Your browser doesn't support javascript.
loading
Disease marker combination enhances patient characterization in the Finnish sarcoidosis patients.
Lahtela, E; Wolin, A; Pietinalho, A; Lokki, M-L; Selroos, O.
Affiliation
  • Lahtela E; Transplantation Laboratory, Medicum, University of Helsinki, Finland. Electronic address: Laura.lahtela@helsinki.fi.
  • Wolin A; Transplantation Laboratory, Medicum, University of Helsinki, Finland.
  • Pietinalho A; Raasepori Health Care Centre, Raasepori, Finland.
  • Lokki ML; Transplantation Laboratory, Medicum, University of Helsinki, Finland.
  • Selroos O; University of Helsinki, Helsinki, Finland.
Respir Med ; 132: 92-94, 2017 Nov.
Article in En | MEDLINE | ID: mdl-29229112
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoidosis / Peptidyl-Dipeptidase A / HLA-DP beta-Chains / HLA-DRB1 Chains Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Respir Med Year: 2017 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoidosis / Peptidyl-Dipeptidase A / HLA-DP beta-Chains / HLA-DRB1 Chains Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Respir Med Year: 2017 Document type: Article Country of publication: Reino Unido